Healthcare AI investors writing $25M+ checks

Investors whose typical check size falls in the $25M+ range for healthcare AI deals. Useful for sizing your round and identifying the right tier of partners.

Checks exceeding $25 million characterize extreme late-stage mega-rounds (Series C, D, and beyond) or massive private equity buyouts. In the AI and MedTech sectors, this capital supports profound infrastructural development, global scaling, and massive clinical deployments.
145 investors match

Within $25M+: top investment stages

Growth (140) Series C (55) Series B (44) Series A (28) Series D+ (22) Seed (14) Pre-Seed (4) Post-IPO (2)
Prima Materia
VC AI T3
Stockholm, Sweden
$25M+
Prima Materia is the investment vehicle co-founded by Daniel Ek of Spotify, operating from Stockholm with a mandate to deploy concentrated capital…
AI/ML in Healthcare Digital Health
Prosus Ventures
VC AI T1
Amsterdam, Netherlands
$25M+
Prosus Ventures is the venture arm of one of the largest global technology investment groups, with deep roots in consumer internet, marketplaces,…
Care Delivery / Tech-Enabled Services Digital Health
PSP Investments
PE T3
New York, United States
$25M+
PSP Investments is one of Canada’s largest pension investment managers, with a New York office among its international presence, deploying long-duration capital…
Care Delivery / Tech-Enabled Services
QIC Healthcare
PE T3
Brisbane, Australia
$25M+
QIC is a Brisbane-headquartered government-owned investment corporation deploying institutional capital across infrastructure, private equity, real estate, and dedicated growth strategies, with a…
Health IT / Healthcare Software Tech-Enabled Services
Quadria Capital
PE T3
New York, United States
$25M+
Quadria Capital is an independent healthcare-focused private equity firm investing with a stated mission of improving the quality and accessibility of clinical…
Care Delivery / Tech-Enabled Services
RA Capital
VC T1
Boston, United States
$25M+
RA Capital Management is a Boston-based investment firm focused exclusively on healthcare, biotechnology, and what it calls planetary health, with a portfolio…
Biotech Diagnostics
Revelstoke Capital Partners
PE T3
Denver, United States
$25M+
Revelstoke Capital Partners is a Denver private equity firm specializing in scaling fragmented, high-growth healthcare service sub-sectors through systematic roll-up strategies. Sub-vertical…
Care Delivery / Tech-Enabled Services
Ridgemont Equity Partners
PE T3
Charlotte, United States
$25M+
Ridgemont Equity Partners is a Charlotte, North Carolina middle-market buyout and growth equity investor active in healthcare and industrial networks. Healthcare sub-vertical…
Care Delivery / Tech-Enabled Services
Sanabil Investments
PE AI T2
Riyadh, Saudi Arabia
$25M+
Sanabil Investments is a wholly owned subsidiary of the Public Investment Fund of Saudi Arabia, deploying more than three billion dollars in…
Biotech Digital Health
Sentinel Capital Partners
PE T3
New York, United States
$25M+
Sentinel Capital Partners is a New York middle-market private equity firm investing across multiple sectors with an active practice in lower-middle-market healthcare…
Care Delivery / Tech-Enabled Services
Silversmith Capital Partners
PE AI T3
Boston, United States
<$250k
Silversmith Capital Partners is a Boston-based growth equity firm that occupies a specific seat in the healthcare software cap table: the round…
Care Delivery / Tech-Enabled Services Digital Health
Sixth Street
PE T3
London, United Kingdom
$25M+
Sixth Street is a global investment firm with a flexible, thematic strategy that funds complex healthcare and pharmaceutical transactions, operating from offices…
Life Sciences Tools Pharma / Therapeutics
Sofina India
VC T2
Brussels, Belgium
$25M+
Sofina is a Brussels-based, family-backed global investment firm with a long-duration capital base, deploying Series B, Series C, and growth-stage checks of…
Care Delivery / Tech-Enabled Services Pharma / Therapeutics
Sofinnova Investments
VC T3
Menlo Park, United States
$25M+
Sofinnova Investments is a longstanding biotech-focused venture firm formerly known as Sofinnova Ventures, investing predominantly in therapeutics across discovery, clinical-stage, and commercial-stage…
Biotech Pharma / Therapeutics
Softbank Vision Fund
PE AI T3
Tokyo, Japan
$25M+
SoftBank Vision Fund is the largest single pool of growth capital in technology, and its healthcare practice has become an increasingly defined…
AI/ML in Healthcare Biotech
AI Tool Finder
AI-powered search. Results may not be comprehensive.